Catalyst Wire Dossier Catalyst Wire Dossier

Aczone 5%

dapsone · Sun Pharmaceutical Industries, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aczone 5%, covering 2017-05-04 to 2017-05-04. Get the full timeline:

Most recent: Clinical Trial Update: Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris [Phase 1]

See pricing